In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
Good morning, and welcome to the Jefferies 2025 Healthcare Conference. It's my pleasure now to introduce David Kirn, CEO; and Chris Simms, Chief Commercial Officer of 4D Molecular Therapeutics. All ...
Jefferies London Healthcare Conference 2025 November 18, 2025 4:30 AM ESTCompany ParticipantsSean McClain - Founder, CEO, ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
According to the latest insights from Mordor Intelligence, the electrostatic precipitators market size is projected to grow ...
EyePoint Pharmaceuticals' DURAVYU trials for wet AMD receive positive DSMC review, highlighting safety and potential for ...
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory ...
AMD's next CPU launch is going to be the Gorgon Point family. Don't wet yourself in excitement; they're primarily refreshed ...
Optometrist Amy Green discussed the importance of OCT in identifying AMD cases during the AOP’s Locum Clinical Skills ...
In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback